Q1 2025 revenue grew 5.07% year-over-year, but net loss widened to RMB 58.95 million, with improved operating cash flow and ongoing major asset restructuring. Stock option cancellations and new grants reflect performance challenges and incentives.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.